PWM
LPCN icon

Prentice Wealth Management’s Lipocine LPCN Stock Holding History

Prentice Wealth Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed -$1K – 214
2021
Q3 		$1K Hold
15
– – ﹤0.01% 322
2021
Q2 		$1K Hold
15
– – ﹤0.01% 318
2021
Q1 		$1K Buy
+15
New +$433 ﹤0.01% 317

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Prentice Wealth Management's LPCN Position: Q4 2021 in Review

Prentice Wealth Management sold out of Lipocine (LPCN) in Q4 2021, closing a stake of 15 shares — an estimated $1K sold.

Prentice Wealth Management first reported a position in LPCN in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 39 funds tracked by Wall St. Rank hold LPCN as of Q4 2021.

  • Prentice Wealth Management reported no remaining Lipocine position as of Q4 2021 after selling out during the quarter.
  • Prentice Wealth Management sold 15 Lipocine shares in Q4 2021, an estimated $1K.
  • Prentice Wealth Management first reported a position in Lipocine in Q1 2021 and held it in 3 quarters.
  • Prentice Wealth Management's Lipocine position peaked at $1K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Lipocine as of Q4 2021.

Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.